Browse by Audience
Skip to content
Papers of the Week
Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound.
Authors
Abstract
IL-31 is a major pruritogen associated with atopic dermatitis (AD). Although a specific antibody for IL-31 receptor has been shown to alleviate pruritus in patients with AD, therapeutic approaches to inhibit IL-31 production remain unexploited. IL-31 production by helper T cells critically depends on the transcription factor EPAS1, which mediates IL31 promoter activation in collaboration with SP1.